Works by Roy, Vivek


Results: 84
    1
    2

    AT-101 Enhances the Antitumor Activity of Lenalidomide in Patients with Multiple Myeloma.

    Published in:
    Cancers, 2023, v. 15, n. 2, p. 477, doi. 10.3390/cancers15020477
    By:
    • Ailawadhi, Sikander;
    • Parrondo, Ricardo D.;
    • Dutta, Navnita;
    • Han, Bing;
    • Ciccio, Gina;
    • Cherukuri, Yesesri;
    • Alegria, Victoria R.;
    • LaPlant, Betsy R.;
    • Roy, Vivek;
    • Sher, Taimur;
    • Edwards, Brett;
    • Lanier, Stephanie;
    • Manna, Alak;
    • Heslop, Keisha;
    • Caulfield, Thomas;
    • Maldosevic, Emir;
    • Storz, Peter;
    • Manochakian, Rami;
    • Asmann, Yan;
    • Chanan-Khan, Asher A.
    Publication type:
    Article
    3
    4
    5

    Unique characteristics and outcomes of therapy-related acute lymphoblastic leukemia following treatment for multiple myeloma.

    Published in:
    Blood Cancer Journal, 2022, v. 12, n. 6, p. 1, doi. 10.1038/s41408-022-00680-y
    By:
    • Parrondo, Ricardo D.;
    • Rahman, Zaid Abdel;
    • Heckman, Michael G.;
    • Wieczorek, Mikolaj;
    • Jiang, Liuyan;
    • Alkhateeb, Hassan B.;
    • Litzow, Mark R.;
    • Greipp, Patricia;
    • Sher, Taimur;
    • Bergsagel, Leif;
    • Fonseca, Rafael;
    • Roy, Vivek;
    • Dispenzieri, Angela;
    • Kharfan-Dabaja, Mohamed A.;
    • Murthy, Hemant S.;
    • Ailawadhi, Sikander;
    • Foran, James M.
    Publication type:
    Article
    6
    7

    Identification of adult Philadelphia-like acute lymphoblastic leukemia using a FISH‐based algorithm distinguishes prognostic groups and outcomes.

    Published in:
    2021
    By:
    • Abdel-Rahman, Zaid H.;
    • Heckman, Michael G.;
    • Anagnostou, Theodora;
    • White, Launia J.;
    • Kloft‐Nelson, Sara M.;
    • Knudson, Ryan A.;
    • Alkhateeb, Hassan B.;
    • Sproat, Lisa Z.;
    • Khera, Nandita;
    • Murthy, Hemant S.;
    • Ayala, Ernesto;
    • Hogan, William J.;
    • Roy, Vivek;
    • Peterson, Jess F.;
    • Kharfan-Dabaja, Mohamed A.;
    • Ketterling, Rhett P.;
    • Litzow, Mark R.;
    • Baughn, Linda B.;
    • Patnaik, Mrinal;
    • Greipp, Patricia T.
    Publication type:
    Letter
    8

    Early post-transplantation factors predict survival outcomes in patients undergoing allogeneic hematopoietic cell transplantation for myelofibrosis.

    Published in:
    Blood Cancer Journal, 2020, v. 10, n. 3, p. 1, doi. 10.1038/s41408-020-0302-9
    By:
    • Jain, Tania;
    • Kunze, Katie L.;
    • Mountjoy, Luke;
    • Partain, Daniel K.;
    • Kosiorek, Heidi;
    • Khera, Nandita;
    • Hogan, William J.;
    • Roy, Vivek;
    • Slack, James L.;
    • Noel, Pierre;
    • Fauble, Veena D. S.;
    • Leis, Jose F.;
    • Sproat, Lisa;
    • Tefferi, Ayalew;
    • Patnaik, Mrinal M.;
    • Mesa, Ruben A.;
    • Palmer, Jeanne
    Publication type:
    Article
    9

    Trends in the risk of second primary malignancies among survivors of chronic lymphocytic leukemia.

    Published in:
    Blood Cancer Journal, 2019, v. 9, n. 10, p. N.PAG, doi. 10.1038/s41408-019-0237-1
    By:
    • Kumar, Vivek;
    • Ailawadhi, Sikander;
    • Bojanini, Leyla;
    • Mehta, Aditya;
    • Biswas, Suman;
    • Sher, Taimur;
    • Roy, Vivek;
    • Vishnu, Prakash;
    • Marin-Acevedo, Julian;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Aulakh, Sonikpreet;
    • Iqbal, Madiha;
    • Manochakian, Rami;
    • Tan, Winston;
    • Chanan-Khan, Asher;
    • Ailawadhi, Meghna
    Publication type:
    Article
    10
    11
    12

    A phase I/II trial of reduced intensity allogeneic hematopoietic cell transplant for hematologic malignancies using cladribine, thiotepa and rabbit antithymocyte globulin.

    Published in:
    Leukemia & Lymphoma, 2013, v. 54, n. 8, p. 1713, doi. 10.3109/10428194.2012.753444
    By:
    • Larsen, Jeremy T.;
    • Hogan, William J.;
    • Micallef, Ivana N.;
    • Dispenzieri, Angela;
    • Gertz, Morie A.;
    • Inwards, David J.;
    • Tun, Han W.;
    • Roy, Vivek;
    • Geyer, Susan M.;
    • Allred, Jacob B.;
    • Wu, Wenting;
    • Ansell, Stephen M.;
    • Elliott, Michelle A.;
    • Tefferi, Ayalew;
    • Porrata, Luis F.;
    • Gastineau, Dennis A.;
    • Lacy, Martha Q.;
    • Litzow, Mark R.
    Publication type:
    Article
    13
    14
    15

    A phase 1/2 of carfilzomib and melphalan conditioning for autologous stem cell transplantation for multiple myeloma (CARAMEL).

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 8, p. 1277, doi. 10.1002/ajh.26990
    By:
    • Visram, Alissa;
    • Hayman, Suzanne R.;
    • Dispenzieri, Angela;
    • Kapoor, Prashant;
    • Lacy, Martha Q.;
    • Gertz, Morie A.;
    • Buadi, Francis K.;
    • Dingli, David;
    • Warsame, Rahma;
    • Kourelis, Taxiarchis;
    • Cook, Joselle;
    • Binder, Moritz;
    • Gonsalves, Wilson;
    • Muchtar, Eli;
    • Leung, Nelson;
    • Roy, Vivek;
    • Rajkumar, S. Vincent;
    • Kumar, Shaji
    Publication type:
    Article
    16
    17
    18

    Clarithromycin (Biaxin)-lenalidomide-low-dose dexamethasone (BiRd) versus lenalidomide-low-dose dexamethasone (Rd) for newly diagnosed myeloma.

    Published in:
    American Journal of Hematology, 2010, v. 85, n. 9, p. 664, doi. 10.1002/ajh.21777
    By:
    • Gay, Francesca;
    • Rajkumar, S. Vincent;
    • Coleman, Morton;
    • Kumar, Shaji;
    • Mark, Tomer;
    • Dispenzieri, Angela;
    • Pearse, Roger;
    • Gertz, Morie A.;
    • Leonard, John;
    • Lacy, Martha Q.;
    • Chen-Kiang, Selina;
    • Roy, Vivek;
    • Jayabalan, David S.;
    • Lust, John A.;
    • Witzig, Thomas E.;
    • Fonseca, Rafael;
    • Kyle, Robert A.;
    • Greipp, Philip R.;
    • Stewart, A. Keith;
    • Niesvizky, Ruben
    Publication type:
    Article
    19
    20
    21
    22

    Impact of Cell of Origin on Outcomes After Autologous Hematopoietic Cell Transplant in Diffuse Large B-Cell Lymphoma.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 2, p. e89, doi. 10.1016/j.clml.2021.08.011
    By:
    • Iqbal, Madiha;
    • Castano, Yennifer Gil;
    • Paludo, Jonas;
    • Rosenthal, Allison;
    • Zhuo Li;
    • Beltran, Manuel;
    • Moustafa, Muhamad Alhaj;
    • Inwards, David;
    • Porrata, Luis;
    • Micallef, Ivana;
    • Bisneto, Jose C. Villasboas;
    • Johnston, Patrick;
    • Ansell, Stephen M.;
    • Reeder, Craig;
    • Murthy, Hemant;
    • Roy, Vivek;
    • Foran, James;
    • Tun, Han W.;
    • Kharfan-Dabaja, Mohamed A.;
    • Ayala, Ernesto
    Publication type:
    Article
    23

    Efficacy of Daratumumab-Based Regimens for the Treatment of Plasma Cell Leukemia.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. 355, doi. 10.1016/j.clml.2021.01.002
    By:
    • Parrondo, Ricardo D.;
    • Moustafa, Muhamad Alhaj;
    • Reeder, Craig;
    • Sher, Taimur;
    • Roy, Vivek;
    • Muchtar, Eli;
    • Warsame, Rahma;
    • Alegria, Victoria;
    • Gonsalves, Wilson;
    • Dingli, David;
    • Hayman, Suzanne;
    • Kapoor, Prashant;
    • Chanan-Khan, Asher A.;
    • Ailawadhi, Sikander
    Publication type:
    Article
    24

    Trends in Early Mortality From Multiple Myeloma: A Population-Based Analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, n. 5, p. e449, doi. 10.1016/j.clml.2020.12.023
    By:
    • Kumar, Vivek;
    • Ailawadhi, Meghna;
    • Dutta, Navnita;
    • Abdulazeez, Mays;
    • Aggarwal, Chander Shekher;
    • Quintero, Gerson;
    • Baksh, Mizba;
    • Roy, Vivek;
    • Taimur Sher;
    • Alegria, Victoria;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Ailawadhi, Sikander
    Publication type:
    Article
    25
    26
    27
    28

    Deep and Durable Responses with Weekly Ixazomib, Lenalidomide, and Dexamethasone in Patients with Newly Diagnosed Multiple Myeloma (NDMM): Long-Term Follow-up of Patients Not Undergoing Stem Cell Transplantation (SCT).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2017, v. 17, p. S335, doi. 10.1016/j.clml.2017.07.151
    By:
    • Kumar, Shaji;
    • Berdeja, Jesus;
    • Niesvizky, Ruben;
    • Lonial, Sagar;
    • Laubach, Jacob;
    • Hamadani, Mehdi;
    • Stewart, A. Keith;
    • Hari, Parameswaran;
    • Roy, Vivek;
    • Vescio, Robert;
    • Kaufman, Jonathan;
    • Berg, Deborah;
    • Liao, Eileen;
    • Rajkumar, Vincent;
    • Richardson, Paul
    Publication type:
    Article
    29
    30
    31
    32

    Utilization of radiation therapy in multiple myeloma: trends and changes in practice.

    Published in:
    Annals of Hematology, 2021, v. 100, n. 3, p. 735, doi. 10.1007/s00277-020-04371-1
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan;
    • Ailawadhi, Meghna;
    • Kanji, Zahara;
    • Jani, Prachi;
    • Fiala, Mark;
    • Abdulazeez, Mays;
    • Ahmed, Salman;
    • Aggarwal, Chander Shekher;
    • Aulakh, Sonikpreet;
    • Hodge, David;
    • Roy, Vivek;
    • Alegria, Victoria R.;
    • Paulus, Aneel;
    • Chanan-Khan, Asher;
    • Sher, Taimur
    Publication type:
    Article
    33
    34
    35
    36
    37
    38

    Trends in multiple myeloma presentation, management, cost of care, and outcomes in the Medicare population: A comprehensive look at racial disparities.

    Published in:
    2018
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Sharma, Mayank;
    • Menghani, Richa;
    • Temkit, M'hamed;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Paulus, Aneel;
    • Aslam, Nabeel;
    • Sher, Taimur;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher;
    • Temkit, M'hamed;
    • Colon-Otero, Gerardo;
    • Chanan-Khan, Asher
    Publication type:
    journal article
    39
    40
    41
    42
    43
    44
    45

    Racial disparity in utilization of therapeutic modalities among multiple myeloma patients: a SEER-medicare analysis.

    Published in:
    Cancer Medicine, 2017, v. 6, n. 12, p. 2876, doi. 10.1002/cam4.1246
    By:
    • Ailawadhi, Sikander;
    • Frank, Ryan D.;
    • Advani, Pooja;
    • Swaika, Abhisek;
    • Temkit, M'hamed;
    • Menghani, Richa;
    • Sharma, Mayank;
    • Meghji, Zahara;
    • Paulus, Shumail;
    • Khera, Nandita;
    • Hashmi, Shahrukh K.;
    • Paulus, Aneel;
    • Kakar, Tanya S.;
    • Hodge, David O.;
    • Colibaseanu, Dorin T.;
    • Vizzini, Michael R.;
    • Roy, Vivek;
    • Colon‐Otero, Gerardo;
    • Chanan‐Khan, Asher A.
    Publication type:
    Article
    46
    47

    Impact of hypoalbuminemia on the prognosis of relapsed/refractory B‐cell lymphoma treated with axicabtagene ciloleucel.

    Published in:
    European Journal of Haematology, 2021, v. 107, n. 1, p. 48, doi. 10.1111/ejh.13609
    By:
    • Melody, Megan;
    • Gandhi, Sangeetha;
    • Rahman, Zaid Abdel;
    • Lengerke‐Diaz, Paula;
    • Gannon, Nicole;
    • Rosenthal, Allison;
    • Truong, Tuan;
    • Novo, Mattia;
    • Brandes, Eva;
    • Lange, Gina;
    • Estby, Breana;
    • Johnston, Patrick;
    • Ansell, Steve;
    • Bennani, N. Nora;
    • Paludo, Jonas;
    • Bisneto, Jose Villasboas;
    • Ayala, Ernesto;
    • Tun, Han W.;
    • Murthy, Hemant S.;
    • Roy, Vivek
    Publication type:
    Article
    48
    49
    50